Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The digital therapeutics market was valued at USD 8.44 Billion in 2025, driven by the growing prevalence of telehealth services across the globe. The market is anticipated to grow at a CAGR of 28.20% during the forecast period of 2026-2035 to achieve a value of USD 101.21 Billion by 2035. The market is experiencing significant growth due to advancements in digital health technology and increasing smartphone penetration. As healthcare shifts towards patient-centric care, digital therapeutics play a crucial role in managing chronic diseases, mental health disorders, and lifestyle-related conditions. The integration of these solutions into integrated healthcare systems enhances accessibility and real-time patient monitoring. Growing collaborations between technology firms and healthcare providers are accelerating market expansion. Additionally, the rising adoption of AI-driven and data-powered digital therapeutics is further shaping the market landscape, driving increased demand across various demographics and healthcare settings.
Base Year
Historical Period
Forecast Period
Other companies in the market include Noom, Inc., Teladoc Health, Inc., Omada Health Inc., Welldoc's BlueStar, CogniFit Inc., Digital Therapeutics Alliance, Boehringer Ingelheim Pharmaceuticals, Inc., 2Morrow® Inc., Canary Health and Click Therapeutics, Inc.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global digital therapeutics market was valued at USD 8.44 Billion in 2025.
The market is anticipated to grow at a CAGR of 28.20% during the forecast period of 2026-2035, and reach USD 101.21 Billion by 2035. The market is driven by AI-powered digital therapeutics that are revolutionising patient care by offering predictive analytics, remote monitoring, and tailored treatment plans.
Diabetes management held a major market share due to the high global prevalence of diabetes and the effectiveness of digital therapeutics in insulin management.
The software/platforms segment represented a significant market share, driven by its scalability, ease of integration with healthcare systems, and personalised treatment plans through mobile apps and cloud-based solutions.
North America leads the market, driven by strong regulatory support, high smartphone adoption, and increasing investment in digital healthcare.
The market is anticipated to grow from USD 8.44 Billion in 2025 to achieve a value of USD 101.21 Billion by 2035.
Major factors include growing chronic disease prevalence, telehealth expansion, rising healthcare costs, and the need for personalised digital health solutions.
Key trends include AI integration, gamification, cognitive behavioural therapy-based solutions, and increasing FDA approvals for prescription digital therapeutics (PDTs).
Common application areas include diabetes, obesity, CVD, respiratory disorders, smoking cessation, CNS diseases and others.
Market segmentation by sales channels includes B2B (payers, employers, pharmaceutical companies, providers, other buyers) and B2C (caregivers, patients).
Major regional markets include North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Key players in the digital therapeutics market include HYGIEIA, DarioHealth Corp., Big Health, Limbix Health, Noom, Inc., Teladoc Health, Inc., Omada Health Inc., Welldoc's BlueStar, CogniFit Inc., Digital Therapeutics Alliance, Boehringer Ingelheim Pharmaceuticals, Inc., 2Morrow® Inc., Click Therapeutics, Inc., and Canary Health.
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124